Bi-69a11, a Novel Akt Inhibitor, Exerts Anti Tumor Effects in Colon Carcinoma by Modulating Akt and its Downstrem Signaling to Potentiate Current Therapeutic Efficacy
JavaScript is disabled for your browser. Some features of this site may not work without it.
Bi-69a11, a Novel Akt Inhibitor, Exerts Anti Tumor Effects in Colon Carcinoma by Modulating Akt and its Downstrem Signaling to Potentiate Current Therapeutic Efficacy